Patent · US Active

Anti-CD19 antibodies

US11497769B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

WUXI BIOLOGICS IRELAND LIMITED · IE

Inventors

Jing Li · Lexington, US
Jieying Liu · Shanghai, CN

Key dates

Filing date	Sep 20, 2018
Grant date	Nov 15, 2022
Priority date	—
Expiry date	Apr 9, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides anti-CD19 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.